Product Information
TOPIRAMATE ER 50 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $6.1331 per EA under NDC 43598094030. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on Nov 17, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598094030
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA217231FDA Approved
11/17/2023
TE Code
AB1
On Market Since
2/1/2026
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 50 MG CAPSULE has been published 26 times since Feb 25, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1331 per EA |
|---|---|
| All-time high | $6.4173 (Jun 10, 2026) |
| All-time low | $5.7954 (Mar 18, 2026) |
| 52-week high | $6.4173 |
| 52-week low | $5.7954 |
| Median price | $6.2008 |
| Average price | $6.1366 |
| Largest weekly change | +8.4% (May 20, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 50 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $6.1331 per EA (NDC 43598094030), effective Aug 19, 2026.
How has the price of TOPIRAMATE ER 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 50 MG CAPSULE?
Since Feb 25, 2026, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has ranged from a low of $5.7954 (Mar 18, 2026) to a high of $6.4173 (Jun 10, 2026), with a median of $6.2008 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 50 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 50 MG SPRINKL CAP, is $3.3778 per EA — about 45% below TOPIRAMATE ER 50 MG CAPSULE.
Who manufactures TOPIRAMATE ER 50 MG CAPSULE?
TOPIRAMATE ER 50 MG CAPSULE (NDC 43598094030) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.